02/13/2025
11:22 AM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/17/2025
4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:30 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
4:03 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:40 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
9:26 AM | Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/05/2024
3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:00 PM | Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
Get the Latest News and Ratings for TARS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
10/02/2024
4:27 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:52 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:34 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:21 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:22 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:23 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:24 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:25 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:26 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:26 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:44 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:45 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:33 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:38 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:40 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:28 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:30 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
3:12 PM | Tarsus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:24 PM | Tarsus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2024
3:25 PM | Tarsus Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
7:34 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
1:56 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
1:06 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:03 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:04 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:08 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:44 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump doesn’t give a damn (Ad) Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks”
I recently met with one of Trump’s longest-serving advisors.
We helped put together a plan to help investors capitalize on Trump’s election.
And we found out these 10 stocks are the most likely to boom… Go here now to find out the names of these 10 stocks. |
03/18/2024
2:44 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:47 PM | Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:57 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:45 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:10 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:11 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:17 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Tarsus Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:22 PM | Tarsus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
8:18 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
